Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Medical Economics|August 14, 2014
Costs associated with adverse events in patients with metastatic renal cell carcinomaRohit BorkerClinical Therapeutics|December 3, 2013
Economic burden of adverse events in patients with metastatic renal cell carcinomaMay Hagiwara, Rohit Borker, Gerry OsterClinical Genitourinary Cancer|December 27, 2012
Treatment patterns: targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world settingGregory Hess, Rohit Borker, Eileen FonsecaPharmacoeconomics|July 6, 2007
A cost-effectiveness analysis of first-line controller therapies for persistent asthmaYa-Chen Tina Shih, Josephine Mauskopf, Rohit BorkerClinical Therapeutics|May 10, 2005
A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combinationKaren L Rascati, Richard H Stanford, Rohit BorkerJournal of Medical Economics|November 13, 2010
Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancerMaureen J Lage, Rohit Borker, Beth Barber, et al.Pharmacoeconomics|October 17, 2002
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthmaKetan Sheth, Rohit Borker, Amanda Emmett, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 3, 2005
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curvesRohit Borker, Amanda Emmett, Priti Jhingran, et al.The American Journal of Managed Care|November 9, 2007
Adherence to K/DOQI practice guidelines for bone metabolism and diseaseTracey Hoy, Maxine Fisher, Beth Barber, et al.Journal of Health Care for the Poor and Underserved|March 5, 2003
Immunization predictors in rural adults under 65 years of ageS Suresh Madhavan, S Alan Rosenbluth, Mayur Amonkar, et al.Pageof 2